tenk.fyi

Kalaris Therapeutics, Inc.

KLRSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$43.4M

37.2% YoY

EPS

$-2.85

94.5% YoY

Cash

$98.1M

5882.6% YoY

FY 2025 · As of 2025-12-31